Browse by category

The Food and Drug Administration (FDA) has approved a Phase II clinical trial for investigational obesity-treating drug pemvidutide. The...

AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...

A Cleveland Clinic study has reported that adults with obesity lost significantly more weight when they had access to medications for...

The FDA has approved Novo Nordisk’s Wegovy (the brand name for once-weekly semaglutide 2.4mg injection in the US) for chronic weight...